 |
 |

Identifying Patients at Risk of Recurrent Venous Thromboembolism
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Eichinger and colleagues1 found that D-dimer levels measured after a single occurrence of idiopathic venous thromboembolism (VTE) were related to future risk of recurrent VTE. Their D-dimer cutoff levels (250 ng/mL, 500 ng/mL, and 750 mg/mL), however, are assay-specific. In ruling out VTE, for example, optimal threshold values for some enzyme-linked immunoassays (ELISAs) are as low as 40 ng/mL but may be more than 500 ng/mL for others.2 Similarly, different quantitative non-ELISAs may require different cutoff values in the exclusion of VTE.3-4 The threshold used by Eichinger et al to define those patients at low risk for recurrence (ie, <250 mg/mL) is half the value used to exclude VTE (<500 ng/mL) with that particular assay (Asserachrom D-dimer, Boehringer Mannheim, Mannheim, Germany).5
Thus it may be possible to state the author's conclusions in more general terms, ie, that D-dimer levels less than half the threshold level used . . . [Full Text of this Article]
Daniel J. Brotman, MD
Department of General Internal Medicine Cleveland Clinic Foundation Cleveland, Ohio
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|